期刊文献+

Percutaneous Radiofrequency Ablation for Hepatic Malignancies 被引量:1

下载PDF
导出
摘要 Objective To study the therapeutic efficay of percutaneous radiofrequency ablation(PRFA)for hepatic malignancies and to definr its indications and its criteria of the curative effect.Methods In 100 patients with histologically of clinically confirmed hepatocellular carcinoma(HCC)or liver metastases we performed PRFA under ultrasound guidance using Le Veen multipolar array meedle electrode and RF 2000 generator.All patients were followed to identify complications and to assess treatment response.Results PRFA was performed in 76 patients with HCC and in 24 with liver metastases.The Alpha-fetoprotein(AFP)levles of the AFP positive HCC patients with inoperable small HCCs decreased to normal in 75.0%(21/28)and decreased markedly in 21.4%(6/28).Complete necrosis of small hepatic malignancies,documented by magnetic resonance imaging(MRI)was achieved in 85.9%(61/71).If the tumor shows iso-or hyper-intensity on Ti-weighted images,and relative hypointensity on T2-weighted images,and no enhanced intensity on dynamic contrast-enhanced MR imaging,it is considered completely coagulated.Conclusion PRFA is a novel local thermal palliative therapy for small hepatic malignancies that is minimally invasive,safe and effective.In patients with large lesions it can be combined with transarterial chemoembolization(TACE).Critera for curative treatment are normalization of serum AFP and /or MRI or CT scan findings showing complete necrosis.
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2002年第3期159-162,共4页 中德临床肿瘤学杂志(英文版)
  • 相关文献

参考文献9

  • 1Tsuzuki T, Sugioka A, Ueda M.Hepatic resection for hepatocellular carcinoma. Surgery, 1990, 107: 511-520.
  • 2Liver Cancer Study Group of Japan. Primary liver cancer in Japan: clinicopathologicfeatures and results of surgical treatment. Ann Surg, 1990, 211: 277-284.
  • 3Choi TK, Lai Edward CS, Fan ST, et al. Results of surgical resection forhepatocellular carcinoma. Hepatogastroenterology, 1990, 37: 172-175.
  • 4Rossi S, DiStasi M, Buscarini E, et al. Percutaneous RF interstitial thermalablation in the treatment of hepatic cancer. AJR, 1996, 167: 759-768.
  • 5Solbiati L, Ierace T, Goldberg SN, et al. Percutaneous US-guided RF tissue ablationof liver metastases: long-term follow up. Radiology, 1997, 202: 205-210.
  • 6Goldberg SN, Gazelle GS, Solbiati L, et al. Ablation of liver tumors usingpercutaneous RF therapy. AJR, 1998, 170:1023-1028.
  • 7Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primaryand metastatic hepatic malignancies. Ann Surg, 1999, 230: 1-8.
  • 8Rose DM, Allegra DP, Bostick PJ, et al. Radiofrequency ablation: a novel primaryand adjunctive ablative technique for hepatic malignancies. Am Surg, 1999, 65: 1009-1014.
  • 9Zhang ZJ, Liu Q, He J, et al. The effect of preoperative transcatheter hepaticarterial chemoembolization on disease-free survival after hepatectomy for hepatocellularcarcinoma. Cancer, 2000, 89: 2606-2612.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部